Disrupt PAD III trial demonstrates safety and effectiveness of intravascular lithotripsy for peripheral artery calcification
ATLANTA, GA (May 19, 2022) – One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with ...